Category Archives: Brain Tumors

Cannabis Extracts Treating Brain Tumors

Marijuana Extracts Can Slow Brain Tumor Growth

Cannabis Extracts Treating Brain Tumors

Cannabis Extracts Treating Brain Tumors

A study published in the journal Molecular Cancer Therapeutics suggests that extracts from cannabis can help beat brain cancer.

Researchers used two active chemical components found within cannabis in addition to traditional radiological treatments used on brain cancer patients. The active chemical components were cannabidiol (CBD) and tetrahydrocannabinol (THC). In tests on mice, it was found that the chemicals helped slow the rate of growth in brain cancers.

Brain cancer is one of the most difficult forms of cancer to treat. It has an extremely low survival rate, with only 10% of cases alive, 5 years after diagnosis.

The research team was based at St George’s, the University of London. Tests involved mice with brain tumors, treated in a number of ways. treated brain tumours in mice in a variety of ways, either without any treatment, the cannabinoids alone, irradiation alone or with the cannabinoids and irradiation at the same time.

According to senior research fellow Dr Wai Liu, “Those treated with both irradiation and the cannabinoids saw the most beneficial results and a drastic reduction in size,”

“In some cases, the tumours effectively disappeared in the animals. This augurs well for further research in humans in the future. – this is a mostly fatal disease at the moment”

This may be an important step forward in combating one of the most dangerous forms of cancer.

Brittany Maynard Euthanasia

Cancer Death Stirs up Euthanasia Debate

Brittany Maynard Euthanasia

Brittany Maynard Euthanasia

Brittany Maynard, a 29-year-old woman with terminal brain cancer, took her own life on Saturday. Maynard had pledged to take her own life 4 weeks ago.

She took her life with euthanasia drugs legally available in Oregon for people with a terminal illness. Maynard vowed to end her life before the cancer symptoms reduced her ability to make decisions for herself.

Brittany and her husband Dan Diaz had to move from California to Portland to take advantage of the euthanasia laws. A statement from Sean Crowley of advocacy group Compassion & Choices said that: “She died as she intended — peacefully in her bedroom, in the arms of her loved ones”.

Maynard was suffering from worsening seizures, headaches, neck pain and other severe brain tumor symptoms. Frequently in pain, she decided to die on her own terms. Her brain tumor was very fast progressing, with diagnosis only occurring 6 months ago. Doctors realized early on that she did not have long to live and would suffer from severe symptoms.

Currently five states in the United States allow euthanasia for terminally ill patients. Maynard’s situation has stirred the debate once more.

New Brain Cancer Drugs

Experimental Brain Tumor Drug Available

New Brain Cancer Drugs

New Brain Cancer Drugs

In a new development, Germany has allowed the sale of an experimental brain cancer drug from Biotherapeutics Inc. The United States biotech company has received a special exemption which allows it to sell the drug for 5 years despite the fact it has not finished clinical trials.

Biotherapeutics also has the ability to apply for a 5 year extension at the end of the trial period. The shares for the biotech company have risen sharply on the stock exchange in response to the news.

The company had been touting the results of it’s cancer drug “DCVax-L” in a number of patients in clinical trials. The drug will be made available in Germany in out patient clinics and hospitals for any patient with cancer that began in the brain. That is despite the fact that the drug has only been tested on people with the sever Glioblastoma multiforme (GBM) form of the disease.

This is the first time that Germany has allowed a drug to be released in this fashion, so presumably academics have seen some very good outcomes from it’s use. This step by Germany may also lead to other countries in the European Union making promising cancer drugs available quickly, including DCVax-L.

The European Union looks favorably upon quick release of new drugs which have not yet won marketing approval, as a way to encourage biotech companies to set up there.

In early tests, patients taking DCVax-L lived 2.5 times as long as most patients undertaking standard treatment. Standard treatment for brain tumors includes surgery, Temodar chemotherapy and radiation.

Late stage trial data for DCVax-L had been delayed which was a cause of some concern for investors, but this news from Germany has made them very happy. In Germany there are more than 3000 cases of the aggressive Glioblastoma multiforme tumors each year and around 4000 lower grade tumors that might benefit from the new drug.

The company are ramping up for full production of the drug, which should be on sale within a few months in Germany.

The new drug could be a massive windfall with over a billion worth of sales potential in the EU and the United States if it is given full approval. The only thing which might get in the way of cancer patients accessing the drug now is the cost – it will most likely cost more than $70’000 per year for the drug.

However when traditional approaches saw most patients surviving around 14 months, patients on DCVax-L plus the standard treatment survived up to 3 years in the early trials without serious side effects. Analysts warn that the early trials consisted of only a small group of 20 patients.

The drug works by making the body’s immune system track down and kill cancer cells. The immune system’s dendritic cells are controlled and they make antibodies using other cells to agressively kill cancer cells.

A patient’s immature dendritic cells are taken from the blood and mixed with dozens of antigens from brain tumor tissue of the patient obtained in surgery. Then it is purified and injected back into the body as a drug. An exciting new approach to cancer treatment and one of the new forms of drugs that will hopefully improve survival rates in years to come.

Brain Cancer Symptoms

Brain Tumor Symptoms Explained

Brain Cancer Symptoms

Brain Cancer Symptoms


There are a lot of probable brain tumor indicators, and most of these can also be found in those who do not have this medical problem. Therefore, many people often overlook the signals they encounter not understanding they can result in a cancer diagnosis. Understanding the common signs of brain cancer will help by warning folks who have these so that they would carry out a brain scan to find out if a brain tumor is there.

Below are the typical brain tumor symptoms:

Migraines. The most common warning sign is a persistent headache. Over 48% of folks with brain cancer encounter long-term headaches, despite the fact that usually experience them diversely and with no constant pattern. Headache which may be a result of a tumor is usually coupled with nausea and vomiting, and will intensify when you bend over.

Seizures. Seizures are the next most commonly seen warning sign. Among all brain tumors signs it is very common with 33% of sufferers confirming a seizure prior to a medical diagnosis. Seizures can also be connected to other diseases which include heart stroke or epilepsy. If someone is told they have epilepsy or high blood pressure, seizures should still be mentioned to a health care professional. However, if it is a person’s first-time experiencing a seizure, it is usually indicative of a new illness that he or she is probably not alert to. One of several potential illnesses this might indicate is a brain tumor. Thus, an individual ought to receive a brain scan soon after the incident.

Eye sight or Hearing Difficulties. A individual with a brain cancer malignancy will also probably encounter some difficulties or abnormalities in eyesight or hearing. About 25% of patients with brain tumors encounter eyesight difficulties. These problems occur when a tumor causes an increased intracranial force on the portions of the brain that handle hearing and vision.

Behavior and Mental Irregularities. Certain changes in behavior and cognitive ability have been reported amongst individuals with brain tumors. These include issues with short term memory, being unable to concentrate, lacking the ability to find the right words to use when talking, and abnormal conduct such as an unusual deficit of patience or loss of inhibitions.

Strange Sensations. Since the brain manages almost all of the body, a tumor might also cause some problems with any part of the body. Typically, these manifest as odd sensations or a weakening sensation in the legs, arms, facial muscles, or head. These warning signs have been recorded in 25% of patients. Even so, a lot of these are also warning signs of a stroke. If these suddenly arise, the patient must be taken to the physician. If a cerebrovascular event is ruled out, then the affected individual will be advised to get a brain scan to examine for tumors.

Brain tumors symptoms and diagnosis may be complicated. When medical doctors are confronted with these symptoms, they typically think about the more common conditions first before they look at brain cancer. However, quite a few doctors have a tendency to take too much time checking different diagnoses, which may bring about a delay in treatment. As a result, trust only a cancer specialist informed about going through the signs and symptoms.